# The Impact of "First-Line" Rhythm Therapy on AF Progression

> **NCT05514860** · NA · UNKNOWN · sponsor: **University of British Columbia** · enrollment: 303 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **PROCEDURE:** Cryoballoon-based PVI
- **DRUG:** Anti-Arrhythmic Drug Therapy

## Key facts

- **NCT ID:** NCT05514860
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2022-09
- **Final completion:** 2022-11
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2022-10-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05514860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05514860, "The Impact of "First-Line" Rhythm Therapy on AF Progression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05514860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*